I think that's likely, but it's understandably difficult to convince anyone to spend a few hundred million dollars to develop vaccine that might never be used.
Seems like a pretty good deal right now. Our economic system has structural pathologies that make it extremely difficult to meaningfully organize whole populations.
Yeah, ok, I think I agree with this. I have to believe that a sustained effort to develop coronavirus vaccines would bear fruit, whether actual vaccines or merely processes and knowledge, even if the particular motivating disease was no longer in circulation.
Given how close SARS and SARS-CoV-2 is, maybe the SARS vaccine could be applied to the current case.